Protara Therapeutics, Inc.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2017 | $9.2M | $44.0M | $21.2M |
| FY2018 | $3.1M | $23.5M | $19.4M |
| FY2019 | $3.4M | $1.2M | $564.0K |
| FY2020 | $3.9M | $203.2M | $168.6M |
| FY2021 | $10.7M | $172.6M | $35.7M |
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2017 | $9.2M | $44.0M | $21.2M |
| FY2018 | $3.1M | $23.5M | $19.4M |
| FY2019 | $3.4M | $1.2M | $564.0K |
| FY2020 | $3.9M | $203.2M | $168.6M |
| FY2021 | $10.7M | $172.6M | $35.7M |